Commonly Used Antibacterial and Antifungal Agents for Hospitalised Paediatric Patients: Implications for Therapy With an Emphasis on Clinical Pharmacokinetics

By Singh J.  

Pediatric Drugs, Vol. 3, Iss. 10, 2001-01 ,pp. : 733-761

Adis International

Access to resources Recommend Favorite

Systemic antifungal prophylaxis beneficial for cancer patients

By  

Inpharma, Vol. 1, Iss. 1611, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Itraconazole and its Active Metabolite Hydroxy-Itraconazole in Paediatric Cystic Fibrosis and Bone Marrow Transplant Patients

By Hennig Stefanie   Wainwright Claire E.   Bell Scott C.   Miller Hugh   Friberg Lena E.   Charles Bruce G.  

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1099-1114

Adis International

Access to resources Recommend Favorite

A Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis

By Gupta A.K.  

Drug Safety, Vol. 22, Iss. 1, 2000-01 ,pp. : 33-52

Adis International

Access to resources Recommend Favorite

Pharmacotherapy approaches to antifungal prophylaxis

By Ng Tzi Bun   Cheung Randy Chi Fai   Ye Xiu juan   Fang Evandro Fei   Chan Yau Sang   Pan Wen Liang   Dan Xiu Li   Yin Cui Ming   Lam Sze Kwan   Lin Peng   Kui Ngai Patrick Hung   Xia Li Xin   Liu Fang   Ye Xiu Yun   Wang He Xiang   Wong Jack Ho  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1695-1705

Informa Healthcare

Access to resources Recommend Favorite